This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics


  • 00
  • 00
  • 00
  • 00
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Lucas Siow
CEO and Co-Founder at ProteinQure


Lucas is the CEO and one of the co-founders of ProteinQure. His background is in applied math and statistics (UC Berkeley and University of Pennsylvania), with an MBA from the University of Toronto. He has worked in numerous industries as a data scientist and management consulting before co-founding ProteinQure. ProteinQure is a five year old startup with 20 employees based in downtown Toronto. ProteinQure is the only computational platform combining AI and molecular dynamics to design exotic peptides and their conjugates. They have worked with three of the top 25 pharma companies in the world, and have multiple projects successfully demonstrating in-vivo success. They utilize non-canonical amino acids and complex scaffolds to engineer potency, stability, specificity and other drug like properties.

Agenda Sessions

  • First De-novo Designed Cyclic Peptides for SORT1 and CNS Delivery